Alkermes Investigational Site

Philadelphia, Pennsylvania 19139

0 studies enrolling now · 12 studies all time

What they study most

Alcohol Dependence, Major Depressive Disorder, Multiple Sclerosis, Narcolepsy Type 2, OIC, Schizophrenia

Studies at this site

• A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2 — Completed
• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study — Completed
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) — Completed
• A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) — Completed
• A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia — Completed
• ALK37-007: Evaluation of Safety and Efficacy of ALKS 37 (RDC-1036) in Adults With Opioid-induced Constipation (OIC) — Completed
• ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence — Completed